Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922308404> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2922308404 abstract "466 Background: Bladder cancer is the fifth most common cancer in the United States. PD-1/PD-L1, a pathway used by cancer cells to evade immune response, correlates with bladder cancer severity and has emerged as a target in bladder cancer treatment. Chromosomal instability is also a prominent feature associated with the development of bladder cancer. A method to unbiasedly analyze PD-L1 expression and DNA content in cells from urine samples will help us better understand bladder cancer. Methods: To evaluate the PD-L1 expression and DNA content, we developed a 4-color flow assay. Cells in urine samples were pelleted, fixed/permeabilized (in incellMAX, IncellDx Inc.) and stained with antibodies against pan-cytokeratin (CK), CD45, PD-L1 and a cell cycle dye. The stained samples were analyzed by a flow cytometer alongside stained control cells. Results: Fifty bladder cancer patient and 15 normal donor urine samples were collected and tested with this assay. We could distinguish epithelial cells (pan-CK+) and white blood cells (WBCs, CD45+) in urine samples and obtain PD-L1 expression and DNA content information simultaneously from these cell populations. The patient samples showed a significantly higher percentage of WBCs with substantial PD-L1 expression. The percentage of PD-L1 positive epithelial cells was not distinguishable between normal donor and patient samples. However, increased post G1 epithelial cells ( > 5%) were observed in a majority of bladder cancer patients, with around 25% of samples showing a DNA index above 1.05. In addition, a comparison of urine collection fixatives showed that incellMAX-fixed samples had the best single cell recovery and DNA content measurement, as shown by lower cell cycle dye staining variability (lower rCV). Statistically significant differences were found between cancer patients and normal samples. Conclusions: We developed a flow cytometry-based method to investigate PD-L1 and DNA content simultaneously in cells from urine samples. Comparing urine samples from bladder cancer patients and normal yielded statistically significant differences that could provide valuable information for bladder cancer patient management." @default.
- W2922308404 created "2019-03-22" @default.
- W2922308404 creator A5015190969 @default.
- W2922308404 creator A5017934723 @default.
- W2922308404 creator A5041742651 @default.
- W2922308404 creator A5045777574 @default.
- W2922308404 creator A5090233891 @default.
- W2922308404 date "2019-03-01" @default.
- W2922308404 modified "2023-09-27" @default.
- W2922308404 title "Urine cell flow cytometry analysis of PD-L1 expression and DNA content for bladder cancer." @default.
- W2922308404 doi "https://doi.org/10.1200/jco.2019.37.7_suppl.466" @default.
- W2922308404 hasPublicationYear "2019" @default.
- W2922308404 type Work @default.
- W2922308404 sameAs 2922308404 @default.
- W2922308404 citedByCount "0" @default.
- W2922308404 crossrefType "journal-article" @default.
- W2922308404 hasAuthorship W2922308404A5015190969 @default.
- W2922308404 hasAuthorship W2922308404A5017934723 @default.
- W2922308404 hasAuthorship W2922308404A5041742651 @default.
- W2922308404 hasAuthorship W2922308404A5045777574 @default.
- W2922308404 hasAuthorship W2922308404A5090233891 @default.
- W2922308404 hasConcept C121608353 @default.
- W2922308404 hasConcept C126322002 @default.
- W2922308404 hasConcept C142724271 @default.
- W2922308404 hasConcept C153911025 @default.
- W2922308404 hasConcept C159654299 @default.
- W2922308404 hasConcept C203014093 @default.
- W2922308404 hasConcept C204232928 @default.
- W2922308404 hasConcept C2779012181 @default.
- W2922308404 hasConcept C2780026642 @default.
- W2922308404 hasConcept C2780339063 @default.
- W2922308404 hasConcept C2780352672 @default.
- W2922308404 hasConcept C502942594 @default.
- W2922308404 hasConcept C553184892 @default.
- W2922308404 hasConcept C71924100 @default.
- W2922308404 hasConcept C86803240 @default.
- W2922308404 hasConcept C8891405 @default.
- W2922308404 hasConcept C96232424 @default.
- W2922308404 hasConceptScore W2922308404C121608353 @default.
- W2922308404 hasConceptScore W2922308404C126322002 @default.
- W2922308404 hasConceptScore W2922308404C142724271 @default.
- W2922308404 hasConceptScore W2922308404C153911025 @default.
- W2922308404 hasConceptScore W2922308404C159654299 @default.
- W2922308404 hasConceptScore W2922308404C203014093 @default.
- W2922308404 hasConceptScore W2922308404C204232928 @default.
- W2922308404 hasConceptScore W2922308404C2779012181 @default.
- W2922308404 hasConceptScore W2922308404C2780026642 @default.
- W2922308404 hasConceptScore W2922308404C2780339063 @default.
- W2922308404 hasConceptScore W2922308404C2780352672 @default.
- W2922308404 hasConceptScore W2922308404C502942594 @default.
- W2922308404 hasConceptScore W2922308404C553184892 @default.
- W2922308404 hasConceptScore W2922308404C71924100 @default.
- W2922308404 hasConceptScore W2922308404C86803240 @default.
- W2922308404 hasConceptScore W2922308404C8891405 @default.
- W2922308404 hasConceptScore W2922308404C96232424 @default.
- W2922308404 hasLocation W29223084041 @default.
- W2922308404 hasOpenAccess W2922308404 @default.
- W2922308404 hasPrimaryLocation W29223084041 @default.
- W2922308404 hasRelatedWork W2101284230 @default.
- W2922308404 hasRelatedWork W2150676471 @default.
- W2922308404 hasRelatedWork W2166013901 @default.
- W2922308404 hasRelatedWork W2344637265 @default.
- W2922308404 hasRelatedWork W2386605958 @default.
- W2922308404 hasRelatedWork W2414188078 @default.
- W2922308404 hasRelatedWork W2430799041 @default.
- W2922308404 hasRelatedWork W2609459726 @default.
- W2922308404 hasRelatedWork W4229375062 @default.
- W2922308404 hasRelatedWork W4283731173 @default.
- W2922308404 isParatext "false" @default.
- W2922308404 isRetracted "false" @default.
- W2922308404 magId "2922308404" @default.
- W2922308404 workType "article" @default.